RBC Capital Mkts Just Issued “Outperform” Rating on Stryker Corporation (SYK)

Stryker Corporation (SYK) was Reiterated by RBC Capital Mkts to “Outperform” according to the research note released today. The brokerage firm has raised the Price Target to $ 135 from a previous price target of $129 . RBC Capital Mkts advised their Clients and Investors in a research report released on Mar 3, 2017.

Based on several research reports , Company shares were Reiterated by RBC Capital Mkts on Mar 3, 2017 to “Outperform”, Firm has raised the Price Target to $ 135 from a previous price target of $129 .Company shares were Reiterated by RBC Capital Mkts on Mar 3, 2017 to “Outperform”, Firm has raised the Price Target to $ 135 from a previous price target of $129 .Company shares were Reiterated by Canaccord Genuity on Jan 25, 2017 to “Buy”, Firm has raised the Price Target to $ 137 from a previous price target of $127 .Stryker Corporation was Downgraded by Needham to ” Underperform” on Jan 6, 2017.

On the company’s financial health, Stryker Corporation reported $1.78 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jan 24, 2017. Analyst had a consensus of $1.76. The company had revenue of $3157.00 million for the quarter, compared to analysts expectations of $3148.44 million. The company’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.

Several company insiders have filed Insider transactions , on Feb 17, 2017, Yin C Becker (VP, Comm. and Public Affairs) sold 4,398 shares at $125.27 per share price. According to the SEC, on Feb 2, 2017, Roch Doliveux (director) purchased 41 shares at $123.12 per share price. On Jan 31, 2017, Louise Francesconi (director) sold 3,716 shares at $122.34 per share price, according to the Form-4 filing with the securities and exchange commission.

Stryker Corporation closed down -0.69 points or -0.53% at $128.58 with 10,05,613 shares getting traded on Monday. Post opening the session at $129, the shares hit an intraday low of $128.41 and an intraday high of $129.66 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Stryker Corporation

You might also like

Leave a Reply

Your email address will not be published. Required fields are marked *